ACELYRIN (SLRN) - Operating Sales Margin

acelyrin.com (SLRN) - corporate logo

Acelyrin, Inc. (SLRN) focuses on developing antibodies for ophthalmology, supporting its patent potential. Development is accelerating through the laboratory automation of cell analysis. The operating margin curve demonstrates profitability dynamics, with the indicator remaining around 0.00. The business possesses macro-resilience, as research rates are independent of GDP cycles, although they remain sensitive to capital liquidity.

acelyrin.com (SLRN): Operating Profit Rate from 02/21/2024 to 05/31/2025

Analytical breakdowns for ACELYRIN (SLRN)

- price and consensus price forecast:
- market capitalization indicators:
Fundamental company valuation:ACELYRIN Inc., SLRN
Core merchandise of acelyrin.com

Acelyrin, Inc. operates in the high-risk biopharmaceutical sector, where the operating margin measures the efficiency of converting revenue into operating profit before taxes and interest. Given the intensive capital burn for clinical trials and competition, the operating margin trend allows investors to assess the business model's resilience to financial threats, avoiding the purchase of an asset at the peak of market euphoria.

Competitor analysis

Operating Profitability haleon.com|Operating Profitability KVUE|Operating Profitability Verona Pharma (VRNA)|Jyong Biotech (MENS) - Operating Profitability Margin|Operating Margin LGND (Ligand Pharma)|Amneal Pharmaceuticals Inc - Operating Profitability|PRGO - Operating Profitability|Alvotech Corp (ALVO) - Operating Sales Margin|LQDA: Operating Margin|Operating Return on Sales glpg.com (GLPG)|Operating Profitability ANI Pharmaceuticals Inc|MNKD: Operating Profit Rate|Operating Sales Margin AMPH (Amphastar)|PCRX - Operating Return on Sales|Operating Margin SPRY (ars-pharma.com)|Operating Profit Rate TBPH|Aquestive Therapeutics, Inc. - Operating Margin|scpharmaceuticals.com - Operating Profit Ratio|Tectonic (TECX) - Operating Profitability|Operating Sales Margin Tonix Pharmaceuticals Inc.|Operating Profitability sxtchina.com|Operating Sales Margin Eupraxia Pharmaceuticals (EPRX)|Operating Margin BHST|EXOZ - Operating Return on Sales|Oramed - Operating Sales Margin|Entera Bio Ltd. (ENTX) - Operating Return on Sales|HYFT - Operating Profitability|ABVC: Operating Profitability|CPIX: Operating Margin|Quantum BioPharma Ltd. - Operating Profit Rate|FGEN (FibroGen Corp) - Operating Margin|Telomir Pharma (TELO) - Profitability of Operations|Operating Profitability Rani Therapeutics Inc (RANI)|SNYR (Synergy CHC Corp.) - Operating Profit Rate|Operating Profitability Rallybio Corporation RLYB|LEXX: Return on Sales by Operating Profit|PULM - Operating Profitability|Operating Profit Rate PTHL (Pheton Holdings)|Aptorum (APM) - Operating Profitability|LYRA (Lyra Therapeutics) - Operating Profitability|Operating Profitability Impact BioMedical Inc|TNF Pharmaceuticals - Operating Profit Margin|Operating Margin YCBD|Operating Margin PainReform Ltd. (PRFX)|Operating Profitability Altamira Therapeutics Ltd CYTO|LIPO (lipella.com) - Operating Profit Margin|OptiNose - Operating Margin|Operating Profit Margin PIRS|PROC: Operating Margin|Petros - Operating Profit Rate|Operating Sales Margin QLI|Operating Margin TFF Pharmaceuticals, Inc.